Literature DB >> 2911307

Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study.

J Avorn1, P Dreyer, K Connelly, S B Soumerai.   

Abstract

Rest homes have become a major component of the health care system for frail elderly persons and deinstitutionalized psychiatric patients. Although psychoactive medications are frequently used in rest homes, there is little detailed information about the extent of such use, its supervision, or its effects. In a survey of a random sample of 55 rest homes in Massachusetts, we found that 55 percent of the residents were taking at least one psychoactive medication. Antipsychotic medications were being administered to 39 percent; of these, 18 percent were receiving two or more such drugs. In a follow-up investigation, we studied 837 residents in 44 rest homes with particularly high levels of antipsychotic-drug use. About half the residents had no evidence of participation by a physician in decisions about their mental health during the year of the study. A third of the residents had performance deficits on mental-status testing that indicated serious cognitive impairment, although the causal relation of such impairment to medication use could not be determined. Six percent had evidence of moderate or severe tardive dyskinesia, probably as a side effect of medication. An assessment of staff competence revealed a low level of comprehension of the purpose and side effects of commonly used psychoactive drugs. We conclude that psychoactive drugs are widely used in rest homes, with little medical supervision or understanding by staff members of their possible side effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911307     DOI: 10.1056/NEJM198901263200406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

1.  Impact of legislation on nursing home care in the United States: lessons for the United Kingdom.

Authors:  C M Hughes; K L Lapane; V Mor
Journal:  BMJ       Date:  1999-10-16

Review 2.  Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Ethical considerations in pharmacotherapy of the aged.

Authors:  M K Goldstein
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

4.  Prescription privileges and psychology: A reply to adams and Bieliauskas.

Authors:  M T Sammons
Journal:  J Clin Psychol Med Settings       Date:  1994-09

5.  Drug use in Swedish nursing homes.

Authors:  C B Claesson; I K Schmidt
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

6.  Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients.

Authors:  H J Kopecky; C R Kopecky; S C Yudofsky
Journal:  Psychiatr Q       Date:  1998

Review 7.  Lessons from geriatric psychiatry in the long-term care setting.

Authors:  J E Streim; D Oslin; I R Katz; P A Parmelee
Journal:  Psychiatr Q       Date:  1997

8.  Serious poisonings among older adults: a study of hospitalization and mortality rates in Massachusetts 1983-85.

Authors:  A Woolf; S Fish; C Azzara; D Dean
Journal:  Am J Public Health       Date:  1990-07       Impact factor: 9.308

Review 9.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

10.  Drug use in a geriatric long-term care setting: comparison between newly admitted and institutionalised patients.

Authors:  Zeev Arinzon; Alexander Peisakh; Aneta Zuta; Yitshal N Berner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.